Primary Undifferentiated Pulmonary Sarcoma (FNCLCC Grade II) in a young adult: A Rare Case and Review of the Literature

Primary pulmonary sarcomas are extremely rare malignant tumors of mesenchymal origin, representing less than 0.5% of all primary lung malignancies. Due to their rarity and non-specific clinical and radiologic features, diagnosis is often delayed. We report the case of a 26-year-old patient presenting with a primary undifferentiated pulmonary sarcoma of FNCLCC grade II. Diagnosis was established through imaging and histopathological examination. Despite initiation of chemotherapy, the disease progressed rapidly and the patient died shortly after the third cycle. We discuss the diagnostic challenges and therapeutic considerations in managing such rare and aggressive tumors.

Authors

Publication Details

Journal
Scholars Journal of Medical Case Reports
Published
2025-05-29
DOI
https://doi.org/10.36347/sjmcr.2025.v13i05.115
Primary Topic
Medical Imaging and Pathology Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Primary Undifferentiated Pulmonary Sarcoma (FNCLCC Grade II) in a young adult: A Rare Case and Review of the Literature

A. El Hajjami, J. Ait Si Abdessadeq, Y. Bouktib, B. Boutakioute et al.
Scholars Journal of Medical Case Reports
Medical Imaging and Pathology Studies
article

Primary Undifferentiated Pulmonary Sarcoma (FNCLCC Grade II) in a young adult: A Rare Case and Review of the Literature

A. El Hajjami, J. Ait Si Abdessadeq, Y. Bouktib, B. Boutakioute, N. Chérif Idrissi, M. Ouali Idrissi, H. Abbay
article en

Abstract

Primary pulmonary sarcomas are extremely rare malignant tumors of mesenchymal origin, representing less than 0.5% of all primary lung malignancies. Due to their rarity and non-specific clinical and radiologic features, diagnosis is often delayed. We report the case of a 26-year-old patient presenting with a primary undifferentiated pulmonary sarcoma of FNCLCC grade II. Diagnosis was established through imaging and histopathological examination. Despite initiation of chemotherapy, the disease progressed rapidly and the patient died shortly after the third cycle. We discuss the diagnostic challenges and therapeutic considerations in managing such rare and aggressive tumors.

Scholars Journal of Medical Case ReportsVol. 13(05)
Openalex Percentile: Top 78%
Medical Imaging and Pathology Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.